Two of the three major U.S. stock indexes just wrapped up their worst quarter in well over two years. The third barely avoided the same fate. The S&P 500 dropped more than 4.5% for the first quarter ...
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the year and the quarter ended December 31, 2022. Revenues are expected to be ...
For the three months ended December 31, 2022, Escalade reported net income of $2.7 million, or $0.20 per diluted share. Sales declined due to softening consumer demand and excess inventories in the ...